Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaudhry, V.
Right arrow Articles by Cornblath, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaudhry, V.
Right arrow Articles by Cornblath, D. R.
NEUROLOGY 1994;44:1459
© 1994 American Academy of Neurology

Inter- and intraexaminer reliability of nerve conduction measurements in patients with diabetic neuropathy

V. Chaudhry, MBBS, MRCP(UK), A. M. Corse, MD, M. L. Freimer, MD, J. D. Glass, MD, E. D. Mellits, ScD, R. W. Kuncl, MD, PhD, S. A. Quaskey, BS and D. R. Cornblath, MD

Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD.

We determined the inter- and intraexaminer reliability of nerve conduction measurements in six patients with diabetic peripheral neuropathy. Each patient was examined by six electromyographers on two separate occasions at least 1 week apart. We obtained attributes of nerve conduction at each examination and analyzed the data by analysis of variance. Intraexaminer reliability was high for 11 of 12 measurements, and interexaminer reliability was high for eight of twelve. Three of the four measurements that varied between examiners were either sensory or motor amplitudes, attributes frequently used to measure disease progression or to assess the result of therapeutic intervention. Our results suggest that longitudinal nerve conduction measurements used to assess worsening or improvement over time should optimally be performed by a single examiner to minimize the degree of variability associated with different examiners.

Address correspondence and reprint requests to Dr. Vinay Chaudhry, Pathology, 600 N. Wolfe Street, Baltimore, MD 21287-6965.

Presented in part at the 45th annual meeting of the American Academy of Neurology, New York, NY, April 1993.

Received December 20, 1993. Accepted in final form February 8, 1994.




This article has been cited by other articles:


Home page
 NeurologyHome page
J. Khan, T. B. Harrison, M. M. Rich, and M. Moss
Early development of critical illness myopathy and neuropathy in patients with severe sepsis
Neurology, October 24, 2006; 67(8): 1421 - 1425.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Nakayama, J. Nakamura, Y. Hamada, S. Chaya, R. Mizubayashi, Y. Yasuda, H. Kamiya, N. Koh, and N. Hotta
Aldose Reductase Inhibition Ameliorates Pupillary Light Reflex and F-Wave Latency in Patients With Mild Diabetic Neuropathy
Diabetes Care, June 1, 2001; 24(6): 1093 - 1098.
[Abstract] [Full Text]

Home page
 NeurologyHome page
D. R. Cornblath, V. Chaudhry, K. Carter, D. Lee, M. Seysedadr, M. Miernicki, and T. Joh
Total neuropathy score: Validation and reliability study
Neurology, November 1, 1999; 53(8): 1660 - 1660.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by AAN Enterprises, Inc.